Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07305415

Integrative Therapeutic Programme to Regulate Expressed Emotions Among Informal Caregivers of People With Dementia

The dual-modal (face-to-face and online approaches), client-customized Caregivers Of dementia Processing Emotions (COPE) programme aims to

1. reduce caregivers' Expressed Emotion (EE), 2. reduce caregivers' depressive symptoms, 3. reduce the behaviourally interactive social dynamic of maladaptation (i.e., dysfunctional dyadic relationship and quality of care), and 4. improve caregivers' perceived stress from PwD's Behavioral and Psychological Symptoms of Dementia (BPSD).

Researchers will compare COPE to a control group (standard therapy) to examine how effective the COPE programme is.

Participants will take part in:

Pretest prior to COPE implementation Post-test after COPE completion Follow up test in 3 months after COPE completion

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Hong Kong

Hong Kong

Location status: Recruiting

Location contact

YU Sau Fung

CONTACT

[email protected]

852 + 39176319

About this study

Primary Purpose Prevention: Assessing the effectiveness of a novel intervention for preventing the development of negative outcomes in caregivers as a result of managing behavioral psychological symptoms of dementia.

Interventional Study Model:

Parallel: Participants are assigned to one of two groups in parallel for the duration of the study.

Model Description:

Participants are assigned to either COPE group or control group on a random basis. Baseline data are collected either face-to-face or online before the implementation. After six weeks of implementation, post-test data will be collected either face-to-face or online. Three months after post-test, follow-up data will be collected either face-to-face or online.

Number of Arms:

Two total arms, one for the COPE intervention group and one for the standard therapy control group.

Masking:

Participants Outcomes Assessors

Allocation:

Randomized: Participants are assigned to intervention groups by chance

Enrollment:

At least 56 subjects are needed for the two arms to allow the most accurate variance estimation for intervention of small to medium standardised effect size (0.2-0.6) at 80% power and 5% level of significance, with a 10% attrition rate. The social workers in the Psychogeriatric Day Hospital (Queen Mary Hospital) will refer the potential family caregivers of PwD to the RA for eligibility screening. Informed consent will be obtained accordingly.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • (1) With a high level of EE as indicated by a cut-off score of 35 or above on the Family Attitude Scale (Chinese version; FAS-C)
  • (2) Provides care at least 4 hours per day
  • (3) Consent to participate
  • (4) No acute psychiatric illness

Exclusion criteria

  • (1) With a score below 35 on the Family Attitude Scale (Chinese version; FAS-C)
  • (2) Provides care no more than 4 hours per day
  • (3) Does not consent to participate
  • (4) With acute psychiatric illness.

Treatment and study plan

Caregivers Of dementia Processing Emotions (COPE)

Behavioral

This is the first study to develop an easily accessible and feasible intervention programme, namely the Caregivers Of dementia Processing Emotions (COPE), to primarily reduce expressed emotion (EE) in family caregivers of PwD via processing one's attributional biases, dysregulated emotion, dysfunctional social dynamics using an integrative therapy. By displacing these negative thoughts and emotions, the integrative therapy has great potential to reduce the depressive symptoms in caregivers and thus mitigate their perceived stress from BPSD. In addition, the interactive social dynamics in the dementia caregiving context can be improved.

Other names: COPE, Mindfulness and Cognitive Behavioral Therapy

Primary outcomes

  1. Family Attitude Scale- Chinese Version

    Time frame: From enrollment to the end of intervention at 7 weeks and end of study at 20 weeks.

    Measure caregivers' expressed emotions (EE) (i.e., criticism and hostility) held towards the PwD.

Secondary outcomes

  1. Center of Epidemiological Studies of Depression Revised - Chinese Version

    Time frame: From enrollment to the end of intervention at 7 weeks and end of study at 20 weeks.

    Assess caregivers' depression

  2. Dyadic Relationship Scale - Chinese Version

    Time frame: From enrollment to the end of intervention at 7 weeks and end of study at 20 weeks.

    Evaluate caregivers' perspective of dyadic and family relationships in their daily caregiving activities

  3. Interaction Quality Scale - Chinese Version

    Time frame: From enrollment to the end of intervention at 7 weeks and end of study at 20 weeks.

    Measure the quality of care.

  4. Neuropsychiatric Inventory - Chinese Version

    Time frame: From enrollment to the end of intervention at 7 weeks and end of study at 20 weeks.

    Assess the severity of BPSD manifested in PwD reported by their caregivers.

Study contacts

Contact information is provided by the study sponsor or research team.

YU Sau Fung, RN, PhD, FHKAN, FAAN, FGSA

CONTACT

[email protected]

852 + 39176319

Sponsors and collaborators

Lead sponsor

The University of Hong Kong

Other

Registry information

Official study title

Integrative Therapeutic Programme to Regulate Expressed Emotions Among Informal Caregivers of People With Dementia: a Pilot Randomized Controlled Trial

Acronym: COPE

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Dec 26, 2025
Registry last updated
Mar 31, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.